APUS
#4763
Apimeds Pharmaceuticals US, Inc. Common Stock
4.5 5 USD
-0.11%
Marktpreis
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-11.31%
Monatliche Änderung
+115.64%
6 month change
+127.50%
Jahresänderung
+247.33%
Vorheriger Schlusskurs
5.1 3
Eröffnungskurs
4.8 0
Tief
4.2 6
Hoch
4.8 0
Finanzen
2026
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Apimeds Pharmaceuticals US, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q1 FY2026
8-K
2025
Annual report, FY2025
Apimeds Pharmaceuticals US, Inc. annual report, FY2025
10-K
Current report, Q4 FY2025
Apimeds Pharmaceuticals US, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Apimeds Pharmaceuticals US, Inc. current report, Q4 FY2025
8-K